The Nebraska Cancer Research Center
Since 1984, The Nebraska Cancer Research Center has been a leader in cancer research, providing local access to National Cancer Institute-sponsored cancer clinical trials. Over 1,900 volunteers have participated in treatment, prevention and control trials through NCRC, helping to identify more effective cancer treatments and improve the quality of life of cancer patients.
- Posted by Jeri on 02/21/2014
- Posted by Jeri on 01/14/2014
- Posted by Jeri on 01/12/2014
WHAT IS A CLINICAL TRIAL?
New Clinical TrialsView all clinical trials available at NCRC.
E2511: Small Cell Lung Cancer - Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination with Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer
E1A11: Hematology - A Randomized Phase III Trial of Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
RU261206I: Melanoma - Randomized Phase II Study of AB (nab-paclitaxel [Abraxane™], Bevacizumab) versus Ipilimumab for 1st Line Therapy of Unresectable Stage IV Metastatic Malignant Melanoma (BRAF V600E Negative)
S1207: Breast - A Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy.